Circio Holding ASA (CRNA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.069x

Based on the latest financial reports, Circio Holding ASA (CRNA) has a cash flow conversion efficiency ratio of 2.069x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-25.66 Million ≈ $-2.70 Million USD) by net assets (Nkr-12.40 Million ≈ $-1.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CRNA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Circio Holding ASA - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Circio Holding ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Circio Holding ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Circio Holding ASA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CTT Systems AB
ST:CTT
-0.034x
Gozde Girisim Sermayesi Yatirim Ortakligi AS
IS:GOZDE
0.120x
Firm Capital Property Trust
TO:FCD-UN
0.031x
BF Investment Limited
NSE:BFINVEST
0.001x
Groupe Sfpi
PA:SFPI
0.132x
CoreCard Corp
NYSE:CCRD
0.112x
Pacific Hospital Supply Co Ltd
TWO:4126
0.067x
HealWELL AI Inc.
TO:AIDX
0.041x

Annual Cash Flow Conversion Efficiency for Circio Holding ASA (2020–2025)

The table below shows the annual cash flow conversion efficiency of Circio Holding ASA from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Circio Holding ASA.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr-12.49 Million
≈ $-1.31 Million
Nkr-45.82 Million
≈ $-4.82 Million
3.668x +13.21%
2024-12-31 Nkr-12.51 Million
≈ $-1.32 Million
Nkr-40.53 Million
≈ $-4.27 Million
3.240x +257.97%
2023-12-31 Nkr-98.54 Million
≈ $-10.37 Million
Nkr-89.20 Million
≈ $-9.39 Million
0.905x +102.13%
2022-12-31 Nkr2.57 Million
≈ $270.02K
Nkr-108.84 Million
≈ $-11.45 Million
-42.417x -20647.19%
2021-12-31 Nkr417.73 Million
≈ $43.96 Million
Nkr-85.40 Million
≈ $-8.99 Million
-0.204x +31.25%
2020-12-31 Nkr372.59 Million
≈ $39.21 Million
Nkr-110.79 Million
≈ $-11.66 Million
-0.297x --

About Circio Holding ASA

OL:CRNA Norway Biotechnology
Market Cap
$183.97 Million
Nkr1.75 Billion NOK
Market Cap Rank
#16971 Global
#137 in Norway
Share Price
Nkr7.35
Change (1 day)
-9.59%
52-Week Range
Nkr0.58 - Nkr14.40
All Time High
Nkr676.52
About

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more